Novartis AG ADR (NVS) Social Stream
NOVARTIS AG (NVS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NVS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 7 | $108 | $100 | $104.333 | $104.82 | -0.46% |
| 2022-01-17 | 8 | $105 | $100 | $102.666 | $104.82 | -2.05% |
| 2022-03-08 | 7 | $105 | $100 | $103 | $104.82 | -1.74% |
| 2022-04-13 | 6 | $105 | $100 | $103 | $104.82 | -1.74% |
| 2022-05-16 | 6 | $106 | $100 | $103.666 | $104.82 | -1.1% |
| 2022-08-26 | 6 | $105 | $97 | $101.666 | $104.82 | -3.01% |
| 2022-09-27 | 7 | $105 | $97 | $101.666 | $104.82 | -3.01% |
| 2022-10-25 | 7 | $105 | $97 | $101 | $104.82 | -3.64% |
| 2022-11-21 | 7 | $105 | $92 | $99.333 | $104.82 | -5.23% |
| 2022-12-05 | 7 | $105 | $101 | $102.666 | $104.82 | -2.05% |
| 2022-12-20 | 7 | $107 | $102 | $104.666 | $104.82 | -0.15% |
| 2023-01-16 | 7 | $108 | $102 | $105 | $104.82 | 0.17% |
| 2023-02-17 | 8 | $108 | $102 | $105 | $104.82 | 0.17% |
| 2023-03-27 | 8 | $108 | $102 | $105 | $104.82 | 0.17% |
| 2023-04-18 | 8 | $113.5 | $105 | $108.833 | $104.82 | 3.83% |
| 2023-04-25 | 8 | $113.5 | $105 | $110.166 | $104.82 | 5.1% |
| 2023-04-26 | 8 | $120 | $105 | $112.333 | $104.82 | 7.17% |
| 2023-07-17 | 8 | $120 | $105 | $114 | $104.82 | 8.76% |
| 2023-07-19 | 8 | $124 | $105 | $115.333 | $104.82 | 10.03% |
| 2023-07-23 | 8 | $124 | $105 | $116.666 | $104.82 | 11.3% |
| 2023-09-05 | 8 | $124 | $105 | $116 | $104.82 | 10.67% |
| 2023-10-02 | 8 | $129 | $105 | $117.666 | $104.82 | 12.26% |
| 2023-10-04 | 8 | $119 | $105 | $114 | $104.82 | 8.76% |
| 2023-10-25 | 8 | $118 | $105 | $111 | $104.82 | 5.9% |
| 2023-12-05 | 8 | $118 | $105 | $111.333 | $104.82 | 6.21% |
| 2023-12-26 | 8 | $125 | $105 | $113.666 | $104.82 | 8.44% |
The Trend in the Analyst Price Target
Over the past 15 months, NVS's average price target has gone up $12.67.
Over the past 51 weeks, NVS's average upside potential has been 15.46%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-16 | 7 | 108 | 102 | 105.000 | 91.06 | 15.31% |
| 2023-05-02 | 8 | 120 | 105 | 114.000 | 103.54 | 10.1% |
| 2023-10-17 | 8 | 118 | 105 | 111.000 | 96.49 | 15.04% |
| 2023-12-05 | 8 | 118 | 105 | 111.333 | 96.97 | 14.81% |
| 2023-12-26 | 8 | 125 | 105 | 113.666 | 98.55 | 15.34% |
NVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.25 | 3 | 0 | 5 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
NVS's average broker recommendation rating worsened by 0.45 over the prior 38 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how NOVARTIS AG fares relative to all US stocks, note that its variance in analysts' estimates is lower than -99.56% of that group.
- NOVARTIS AG's number of analysts covering the stock is greater than 99.75% of stocks in the mega market cap category.
- NVS has a higher average analyst price target than 2322.98% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, NOVARTIS AG's upside potential (average analyst target price relative to current price) is higher than 380.54% of them.
In the Pharmaceutical Products industry, ABBV, MRK, and JNJ are the three stocks most similar to NOVARTIS AG regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding NVS using the data that counts. Try POWR Ratings for free.